Markets:

Overview

News

Currencies

International

Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

14.87 +0.26 (+1.78%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements ↗

April 10, 2025

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing...

Via Benzinga

Topics Animal Testing

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 10, 2025

Via Benzinga

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet ↗

April 04, 2025

Via Benzinga

Simulations Plus Posts Better-Than-Expected Results, Joins Savers Value Village, MarketAxess Holdings And Other Big Stocks Moving Higher On Friday ↗

April 04, 2025

Via Benzinga

Simulations Plus Q1 Earnings Assessment ↗

January 07, 2025

Via Benzinga

What to Expect from Simulations Plus's Earnings ↗

October 22, 2024

Via Benzinga

Breaking Down Simulations Plus: 2 Analysts Share Their Views ↗

September 12, 2024

Via Benzinga

US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert ↗

April 04, 2025

U.S. stock futures continued to decline on Friday after a bloodbath on Thursday following the introduction of Donald Trump's tariffs.

Via Benzinga

Topics Government

Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday ↗

April 04, 2025

Via Benzinga

Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

April 03, 2025

From Simulations Plus, Inc.

Via Business Wire

Earnings Scheduled For April 3, 2025 ↗

April 03, 2025

Via Benzinga

Top 3 Health Care Stocks That Are Set To Fly This Month ↗

March 26, 2025

Via Benzinga

Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date

March 20, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum

March 10, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences

February 04, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

January 22, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

January 13, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

January 07, 2025

From Simulations Plus, Inc.

Via Business Wire

Earnings Scheduled For January 7, 2025 ↗

January 07, 2025

Via Benzinga

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

December 17, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in the BTIG Digital Health Forum

November 19, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

November 13, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in the Stephens Annual Investment Conference

November 06, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations

October 30, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results

October 23, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

October 09, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

October 08, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 28, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions

August 23, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Releases DILIsym® X

August 01, 2024

From Simulations Plus, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.